News related to Soma (Carisoprodol) and/or conditions it is approved for
Aradigm Presents Phase 2 Data On Inhaled Liposomal Ciprofloxacin In Cystic Fibrosis At The North American Cystic Fibrosis Conference
Source: Cystic Fibrosis News From Medical News Today [2008.10.26]
Aradigm Corporation (OTCBB: ARDM) it is presenting data from its Phase 2 study of inhaled liposomal ciprofloxacin (ARD-3100) in cystic fibrosis (CF) patients at the 22nd Annual North American Cystic Fibrosis (NACF) conference in Orlando, Florida. Completed in June 2008, the study was an open-label, two week efficacy and safety trial of once daily inhaled liposomal ciprofloxacin in 22 CF patients conducted at leading CF centers in Australia and New Zealand.
Relapsed Ovarian Cancer Responds to Pegylated Liposomal Doxorubicin-Carboplatin
Source: Medscape Pharmacotherapy Headlines [2004.06.10]
The treatment reduces alopecia and neurotoxicity.
Medscape Medical News
Peggy Peck
New CT Scanner From Siemens Healthcare Sets The Bar Higher
Source: MRI / PET / Ultrasound News From Medical News Today [2008.11.26]
With the Somatom Definition Flash, Siemens Healthcare is introducing a CT scanner that will set new standards regarding speed and dose reduction. The system requires only a fraction of the radiation dose that systems previously required to scan even the tiniest anatomical details faster than ever before. The Somatom Definition Flash is a new dual-source CT from Siemens, featuring two X-ray tubes that simultaneously revolve around the patient's body.
ASRM: Preimplantation Genetic Screening Reduces Recurrent Pregnancy Loss in IVF
Source: MedPage Today Endocrinology [2008.11.21]
SAN FRANCISCO (MedPage Today) -- Screening embryos for chromosomal abnormalities before implantation can significantly reduce miscarriage rates in women with idiopathic recurrent pregnancy loss, according to the largest study to date in this population.
Prenatal Diagnosis Improved By Microarray Analysis
Source: Pregnancy / Obstetrics News From Medical News Today [2008.11.18]
A "chip" or array that can quickly detect disorders such as Down syndrome or other diseases associated with chromosomal abnormalities proved an effective tool in prenatal diagnosis in a series of 300 cases at Baylor College of Medicine, said researchers in a report that appears in the current issue of the journal Prenatal Diagnosis. In the report, a team led by Dr. Arthur Beaudet and Dr.
Raptor Pharmaceuticals Corp. Receives FDA Orphan Drug Designation For Cysteamine In Huntington's Disease
Source: Huntingtons Disease News From Medical News Today [2008.06.10]
Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), announced that the U.S. Food and Drug Administration ("FDA") has granted orphan drug designation for cysteamine bitartrate ("cysteamine") for the treatment of Huntington's disease ("HD"). Cysteamine is currently approved by the FDA and European Medicines Agency ("EMEA") to treat nephropathic cystinosis ("cystinosis"), a rare lysosomal storage disease.
Ultraviolet B light exposure increases risk of skin cancer
Source: The Doctors Lounge - Dermatology
Inability to repair chromosomal damage caused by UV-B radiation increases risk of basal cell and squamous cell carcinomas.
FDA Clears The DPL (Deep Penetrating Light) Therapy System For Over-the-Counter - Home Use
Source: Arthritis / Rheumatology News From Medical News Today [2008.11.18]
LED Technologies, LLC announced today that the U.S. Food and Drug Administration (FDA) cleared their DPL™ Therapy System for the relaxation of muscles and relief of muscle spasms, temporary relief of minor muscle and joint aches, pains and stiffness; temporary relief of minor pain and stiffness associated with arthritis; and to temporarily increase local blood circulation.
|
